BCL11B activated T-ALL/LBL is a new genetic subtype recognized by the ICC, which encompasses ~ 30% of ETP ALL and is driven mostly by BCL11B rearrangements (Table 12). The gene discussed is BCL11B; the disease is intrahepatic cholangiocarcinoma.